Understanding Mainstreaming in Genomic Testing for Lynch Syndrome
Mainstreaming in healthcare involves shifting genomic testing from Clinical Genetics to various specialties, such as cancer MDTs. This process impacts consent for genetic testing and result communication. NDRS data analyzes the time to diagnosis, while training and resources focus on why mainstreaming is crucial in Lynch Syndrome testing. Contacts for more information are provided.
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. Download presentation by click this link. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
E N D
Presentation Transcript
Mainstreaming Sarah John Lynch Nurse Facilitator SWGMSA
Mainstreaming refers to the shift of genomic testing away from the Clinical Genetics to other clinics and specialities. Within the Lynch Syndrome testing pathway, this means healthcare professionals in cancer MDTs become directly involved in consenting patients for germline genetic testing and communicating the results.
Contacts: Sarah John Sarah.brook2@nbt.nhs Siobhan John siobhan.john@nhs.net
